SOPHIA GENETICS SA's ticker is and the CUSIP is H82027105. A total of 37 filers reported holding SOPHIA GENETICS SA in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $31,096,185 | -7.1% | 6,789,560 | 0.0% | 0.15% | -2.0% |
| Q1 2024 | $33,472,531 | +4.7% | 6,789,560 | 0.0% | 0.15% | +5.5% |
| Q4 2023 | $31,978,828 | +84.7% | 6,789,560 | 0.0% | 0.14% | +59.3% |
| Q3 2023 | $17,313,378 | -43.1% | 6,789,560 | 0.0% | 0.09% | -38.1% |
| Q2 2023 | $30,417,229 | -9.9% | 6,789,560 | 0.0% | 0.15% | -18.3% |
| Q1 2023 | $33,744,113 | +141.3% | 6,789,560 | 0.0% | 0.18% | +122.2% |
| Q4 2022 | $13,986,494 | -21.7% | 6,789,560 | 0.0% | 0.08% | -23.6% |
| Q3 2022 | $17,857,000 | -27.3% | 6,789,560 | 0.0% | 0.11% | -20.9% |
| Q2 2022 | $24,578,000 | -53.2% | 6,789,560 | 0.0% | 0.13% | -44.2% |
| Q1 2022 | $52,483,000 | -45.2% | 6,789,560 | 0.0% | 0.24% | -38.9% |
| Q4 2021 | $95,733,000 | -20.9% | 6,789,560 | 0.0% | 0.39% | -21.9% |
| Q3 2021 | $121,099,000 | – | 6,789,560 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 2,022,552 | $35,455,000 | 1.04% |
| GENERATION INVESTMENT MANAGEMENT LLP | 6,789,560 | $121,099,000 | 0.50% |
| GENERAL ELECTRIC CO | 1,111,111 | $19,477,776 | 0.36% |
| Monashee Investment Management LLC | 80,000 | $1,402,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 450,010 | $7,889,000 | 0.24% |
| Lombard Odier Asset Management (Switzerland) SA | 145,670 | $2,554,000 | 0.16% |
| Moloney Securities Asset Management, LLC | 29,250 | $513,000 | 0.09% |
| RTW INVESTMENTS, LP | 300,000 | $5,259,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 308,531 | $5,409,000 | 0.06% |
| CREDIT SUISSE AG/ | 1,882,348 | $32,998,000 | 0.02% |